ERFONRILIMAB

UNII:	9NP50O6YSA
Formula:
Preferred Substance Name:	ERFONRILIMAB

2367013-69-0
ERFONRILIMAB [INN]
IMMUNOGLOBULIN G (266-SERINE), BISPECIFIC, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN-CAMELUS BACTRIANUS MONOCLONAL KN046 .GAMMA.-CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GAP) FUSION PROTEIN WITH IMMUNOGLOBULIN G ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-CAMELUS BACTRIANUS MONOCLONAL KN046 .GAMMA.-CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GS) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), DIMER
KN 046 [WHO-DD]
KN046
KN-046

Common Chemistry
i
Inxight Drugs
i
GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ERFONRILIMAB

Synonyms and Mappings

Resources